These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 635475)

  • 1. Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland.
    Peltola H
    Scand J Infect Dis; 1978; 10(1):41-4. PubMed ID: 635475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination against meningococcal group A disease in Finland 1974-75.
    Peltola H; Mäkelä PH; ELO O; Pettay O; Renkonen OV; Sivonen A
    Scand J Infect Dis; 1976; 8(3):169-74. PubMed ID: 788143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70.
    Gold R; Artenstein MS
    Bull World Health Organ; 1971; 45(3):279-82. PubMed ID: 5316907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningococcal vaccines. Current status and future possibilities.
    Peltola H
    Drugs; 1998 Mar; 55(3):347-66. PubMed ID: 9530542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of epidemic group A meningococcal disease in Auckland.
    Lennon D; Gellin B; Hood D; Leach DT; Woods GM; Williams P; Thakur S; Crombie D
    N Z Med J; 1993 Jan; 106(948):3-6. PubMed ID: 8423925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients.
    Drogari-Apiranthitou M; Fijen CA; Van De Beek D; Hensen EF; Dankert J; Kuijper EJ
    Clin Exp Immunol; 2000 Feb; 119(2):311-6. PubMed ID: 10632668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-meningococcal polysaccharide vaccines].
    Gómez JA; Ferreirós CM; Criado MT
    Enferm Infecc Microbiol Clin; 1997; 15(7):347-8. PubMed ID: 9410045
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.
    Tashani M; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Rashid H; Findlow H; Borrow R; Booy R
    Vaccine; 2018 Jul; 36(29):4375-4382. PubMed ID: 29880243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
    Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A
    Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic behavior of meningococcal vaccines].
    Requejo HI
    Rev Saude Publica; 1997 Aug; 31(4):402-16. PubMed ID: 9595770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine prevention of meningococcal disease, coming soon?
    Morley SL; Pollard AJ
    Vaccine; 2001 Dec; 20(5-6):666-87. PubMed ID: 11738731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of meningococcal disease by group C polysaccharide vaccine.
    Artenstein MS; Gold R; Zimmerly JG; Wyle FA; Schneider H; Harkins C
    N Engl J Med; 1970 Feb; 282(8):417-20. PubMed ID: 4983754
    [No Abstract]   [Full Text] [Related]  

  • 14. Meningococcal disease and its control with meningococcal polysaccharide vaccines.
    Galazka A
    Bull World Health Organ; 1982; 60(1):1-7. PubMed ID: 6979414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil.
    de Moraes JC; Perkins BA; Camargo MC; Hidalgo NT; Barbosa HA; Sacchi CT; Landgraf IM; Gattas VL; Vasconcelos Hde G
    Lancet; 1992 Oct; 340(8827):1074-8. PubMed ID: 1357461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of group-A meningococcal vaccine in army recruits in Finland.
    Mäkelä PH; Käyhty H; Weckström P; Sivonen A; Renkonen OV
    Lancet; 1975 Nov; 2(7941):883-6. PubMed ID: 53370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the effectiveness of targeted vaccination with the meningococcal polysaccharide A and C vaccine in one location in the Czech Republic].
    Krízová P; Vlcková J; Bobák M
    Epidemiol Mikrobiol Imunol; 1995 Mar; 44(1):9-14. PubMed ID: 7757351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants.
    Rennels M; King J; Ryall R; Papa T; Froeschle J
    Pediatr Infect Dis J; 2004 May; 23(5):429-35. PubMed ID: 15131466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial.
    Choo S; Zuckerman J; Goilav C; Hatzmann E; Everard J; Finn A
    Vaccine; 2000 Jun; 18(24):2686-92. PubMed ID: 10781855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.